In this model system, TLR7 activation, similarly to FPR1 in the GI tract, sustains the increased expression of the enzymes responsible for SPMs biosynthesis, the increased secretion of SPMs from cancer cells, the augmented expression of SPM receptors, and finally the reduction of the angiogenic potential of lung cancer cells [52]. This evidence concerns the gene TLR7 and lung carcinoma.